Long-term efficacy of edaravone in patients with acute myocardial infarction

Circulation Journal

Volumn 70, Issue 7, 2006, Pages 832-837

  Tsujita, Kenichi ^a   Shimomura, Hideki ^b   Kaikita, Koichi ^a   Kawano, Hiroaki ^a   Hokamaki, Jun ^a   Nagayoshi, Yasuhiro ^a   Yamashita, Takuro ^a   Fukuda, Masaya ^a   Nakamura, Yoshinori ^b   Sakamoto, Tomohiro ^a   Yoshimura, Michihiro ^a   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Fukuoka Tokushukai Hospital   (Japan)

Author keywords

Antioxidants; Free radicals; Myocardial infarction; Prognosis; Reperfusion

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NORPHENAZONE; PLACEBO; SCAVENGER; THIOREDOXIN; TICLOPIDINE;

ABSENCE OF SIDE EFFECTS; ACUTE HEART INFARCTION; ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DRUG ACTIVITY; DRUG EFFECT; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROTEIN BLOOD LEVEL; Q WAVE; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY;

ACUTE DISEASE; ANTIPYRINE; ARRHYTHMIA; FREE RADICAL SCAVENGERS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; THIOREDOXIN; TIME FACTORS;

EID: 33745536062     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.832     Document Type: Article

References (37)

1. McCord JM. Oxygen-derived free radicals in post-ischemic injury. N Engl J Med 1985; 312: 159-163.
2. Flaherty JT. Myocardial injury mediated by oxygen free radicals. Am J Med 1991; 91: 3C79S-3C85S.
3. Tsutsui H. Novel pathophysiological insight and treatment strategies for heart failure. Circ J 2004; 68: 1095-1103.
4. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Munzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104: 2673-2678.
5. Jolly SR, Kane WJ, Bailie MB, Abrams GD, Lucchesi BR. Canine myocardial reperfusion injury: Its reduction by the combined administration of superoxide dismutase and catalase. Circ Res 1984; 54: 277-285.
6. Altavilla D, Bazzani C, Squadrito F, Cainazzo MM, Mioni C, Bertolini A, et al. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-κB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res 2000; 47: 515-528.
7. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-786.
8. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349: 1715-1720.
9. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Lancet 1999; 354: 447-455.
10. The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342: 154-160.
11. Rice-Evans CA, Diplock AT. Current status of antioxidant therapy. Free Radic Biol Med 1993; 15: 77-96.
12. Bulkley GB. Free radicals and other reactive oxygen metabolites: Clinical relevance and the therapeutic efficacy of antioxidants therapy. Surgery 1993; 113: 479-483.
13. Nishi H, Watanabe T, Sakurai H, Yuki S, Ishibashi A. Effect of MCI-186 on brain edema in rats. Stroke 1989; 20: 1236-1240.
14. Abe K, Yuki S, Kogure K. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 1988; 19: 480-485.
15. Watanabe T, Egawa M. Effect of an antistroke agent MCI-186 on cerebral arachidonate cascade. J Pharmacol Exp Ther 1994; 271: 1624-1629.
16. The Edaravone Acute Brain Infarction Study Group. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction: Randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis 2003; 15: 222-229.
17. Minhaz U, Tanaka M, Tsukamoto H, Watanabe K, Koide S, Shohtsu A, et al. Effect of MCI-186 on postischemic reperfusion injury in isolated rat heart. Free Radic Res 1996; 24: 361-367.
18. Wu TW, Zeng LH, Wu J, Fung KP. Myocardial protection of MCI-186 in rabbit ischemia-reperfusion. Life Sci 2002; 71: 2249-2255.
19. Tsujimoto I, Hikoso S, Yamaguchi O, Kashiwase K, Nakai A, Takeda T, et al. The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy. Hypertension 2005; 45: 921-926.
20. Tsujita K, Shimomura H, Kawano H, Hokamaki J, Fukuda M, Yamashita T, et al. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am J Cardiol 2004; 94: 481-484.
21. Goodman SG, Langer A, Ross AM, Wildermann NM, Barbagelata A, Sgarbossa EB, et al. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: Angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy: GUSTO-I Angiographic Investigators. Circulation 1998; 97: 444-450.
22. Nakamura H, Matsuda M, Furuke K, Kitaoka Y, Iwata S, Toda K, et al. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett 1994; 42: 75-80.
23. Ohira A, Honda O, Gauntt CD, Yamamoto M, Hori K, Masutani H, et al. Oxidative stress induces adult T cell leukemia derived factor/thioredoxin in the rat retina. Lab Invest 1994; 70: 279-285.
24. Nakamura H, De Rosa S, Roederer M, Anderson MT, Dubs JG, Yodoi J, et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 1996; 8: 603-611.
25. Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, et al. Serum thioredoxin and α-tocopherol concentrations in patients with major risk factors. Circ J 2005; 69: 291-294.
26. Kawano H, Yasue H, Hirai N, Yoshida T, Fukushima H, Miyamoto S, et al. Effects of transdermal and oral estrogen supplementation on endothelial function, inflammation and cellular redox state. Int J Clin Pharmacol Ther 2003; 41: 346-353.
27. Hirai N, Kawano H, Yasue H, Shimomura H, Miyamoto S, Soejima H, et al. Attenuation of nitrate tolerance and oxidative stress by an angiotensin II receptor blocker in patients with coronary spastic angina. Circulation 2003; 108: 1446-1450.
28. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: Phase 1 findings. N Engl J Med 1985; 312: 932-936.
29. Rajesh KG, Sasaguri S, Suzuki R, Maeda H. Antioxidant MCI-186 inhibits mitochondrial permeability transition pore and upregulates Bcl-2 expression. Am J Physiol Heart Circ Physiol 2003; 285: H2171-H2178.
30. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001; 88: 529-535.
31. Tsutsui H, Ide T, Shiomi T, Kang D, Hayashidani S, Suematsu N, et al. 8-Oxo-dGTPase, which prevents oxidative stress-induced DNA damage, increases in the mitochondria from failing hearts. Circulation 2001; 104: 2883-2885.
32. Shimomura H, Ogawa H, Takazoe K, Soejima H, Miyamoto S, Sakamoto T, et al. Comparison of urinary biopyrrin levels in acute myocardial infarction (after reperfusion therapy) versus stable angina pectoris and their usefulness in predicting subsequent cardiac events. Am J Cardiol 2002; 90: 108-111.
33. Miyamoto S, Sakamoto T, Soejima H, Shimomura H, Kajiwara I, Kojima S, et al. Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction. Am Heart J 2003; 146: 465-471.
34. Soejima H, Suefuji H, Miyamoto S, Kajiwara I, Kojima S, Hokamaki J, et al. Increased plasma thioredoxin in patients with acute myocardial infarction. Clin Cardiol 2003; 26: 583-587.
35. Nagayoshi Y, Kawano H, Hokamaki J, Miyamoto S, Kojima S, Shimomura H, et al. Urinary 8-hydroxy-2′-deoxyguanosine levels increase after reperfusion in acute myocardial infarction and may predict subsequent cardiac events. Am J Cardiol 2005; 95: 514-517.
36. Jitsuiki D, Higashi Y, Goto C, Kimura M, Noma K, Hara K, et al. Effect of edaravone, a novel free radical scavenger, on endothelium-dependent vasodilation in smokers. Am J Cardiol 2004; 94: 1070-1073.
37. Janiszewski M, Pasqualucci CA, Souza LC, Pileggi F, da Luz PL, Laurindo FR. Oxidized thiols markedly amplify the vascular response to balloon injury in rabbits through a redox active metal-dependent pathway. Cardiovasc Res 1998; 39: 327-338.